Drug Search Results
More Filters [+]

MMV-390048

Alternative Names: mmv-390048, mmv390048, mmv 390048
Latest Update: 2023-09-01
Latest Update Note: PubMed Publication

Product Description

Mechanisms of Action: PI4K Inhibitor

Novel Mechanism: Yes

Modality: Small Molecule

Route of Administration: Oral

FDA Designation: None *

Approval Status: Not Approved

Approved Countries: None

Approved Indications: None

Known Adverse Events: None

Company: Medicines for Malaria Venture
Company Location:
Company CEO:
Additonal Commercial Interests: None

Clinical Description

Map of Global Clinical Trials for MMV-390048

Countries in Clinic:

Active Clinical Trial Count:

Highest Development Phases

Phase 2: Malaria, Falciparum|Malaria

Phase 1: Malaria|Malaria, Falciparum

Trial

Phase

Trial Status

Disease

Primary Completion Date

Probability of Success

MMV_MMV390048_17_01

P1

Withdrawn

Malaria, Falciparum

2018-09-01

MMV_MMV390048_16_02

P2

Terminated

Malaria, Falciparum

2018-01-01

MMV_MMV390048_16_01, Part B

P2

Completed

Malaria

2017-01-16

MMV_MMV390048_16_01

P1

Completed

Malaria

2016-12-01

Recent News Events